ArticleClinical nutrition open science2022
Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan.
Article in Clinical nutrition open science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Coffee and Green Tea Consumption With the Risk of COVID-19 Among the Vaccine Recipients in Japan: A Prospective Study.Journal of epidemiology · 2024Article
- Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection.American journal of cancer research · 2024Article
- Green Tea Consumption and the COVID-19 Omicron Pandemic Era: Pharmacology and Epidemiology.Life (Basel, Switzerland) · 2023Article
- Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract.Trends in food science & technology · 2023Review
- A phenome-wide investigation of risk factors for severe COVID-19.Journal of medical virology · 2023Article
- Consumer Choices and Habits Related to Tea Consumption by Poles.Foods (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimThis study examined the association between green tea consumption and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among Japanese.
methodsParticipants were staff of a large referral hospital in Tokyo. Green tea consumption was ascertained via a questionnaire. SARS-CoV-2 infection was identified through in-house records of PCR-confirmed COVID-19 cases or antibody tests. Multiple logistic regression was used to estimate the odds ratio of SARS-CoV-2 infection according to green tea consumption.
resultsOf 2640 participants (767 men and 1873 women; aged 21-75 years), 74 (2.8%) were confirmed or suspected to have been infected with SARS-CoV-2 during the epidemic. Overall, SARS-CoV-2 infection was not significantly associated with green tea consumption. There was a suggestion of a decrease in the odds of this infection associated with green tea consumption of ≥4 cups/day (odds ratio 0.51, 95% confidence interval 0.20-1.31).
conclusionsGreen tea consumption was not appreciably associated with the risk of SARS-CoV-2 infection. A lower odds of infection among those who consumed high green tea consumption deserves further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.